This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrugA study involving a medication or substance.
This study is looking at whether Experimental intervention: MetaCognitive skill Training (MCT) focusing on delusion-relevant metacognitive biases in schizophrenia can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Experimental intervention: MetaCognitive skill Training (MCT) focusing on delusion-relevant metacognitive biases in schizophrenia and complete follow-up assessments.
In Germany
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaOther
Countries
Germany
Sponsor
German Research Foundation (DFG)/Federal Ministry of Education and Research (BMBF) (Germany)
This study is looking at whether A three-arm double blind parallel design trial of placebo, haloperidol and risperidone can help people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This study is looking at a support or therapy approach for people with Schizophrenia, Schizophreniform disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.
This study is looking at care and outcomes for people with Mental and behavioural disorders: schizophrenia and other psychoses, depression, anxiety, neuroses, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to 1, but direct benefit is not guaranteed.
In United Kingdom
Why is this study shown?
This study is directly about Schizophrenia.
Schizophrenia, Depression, ...Other
Countries
United Kingdom
Sponsor
NHS R&D Regional Programme Register - Department of Health (UK)
This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether Intervention arm: Services will receive the GetREAL intervention as developed in Phase 2 can help people with psychosis. Participants take part in Intervention arm: Services will receive the GetREAL intervention as developed in Phase 2 and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Persecutory delusion, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
